Condition: Bronchopulmonary Dysplasia (BPD) · Sponsor: Aristotle University Of Thessaloniki
The Impact of Omega-3 (DHA - Docosahexaenoic Acid) and Omega-6 (ARA - Arachidonic Acid) Supplementation on the Development of Bronchopulmonary Dysplasia in Extremely and Very Preterm Infants (24-29 weeks of gestational age).
This description comes directly from the study's public registry record.
Maria Lithoxopoulou, MD, PhD, MBA, Ass. Prof. · +30 6932883161 · mlithoxopoulou@yahoo.com, lithoxopoulou@auth.gr
Always discuss trial participation with your own doctor first.
| Papageorgiou General Hospital | Thessaloniki, Greece | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07652684